These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22404848)

  • 21. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
    McCann TV; Clark E; Lu S
    J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of weight gain on quality of life among persons with schizophrenia.
    Allison DB; Mackell JA; McDonnell DD
    Psychiatr Serv; 2003 Apr; 54(4):565-7. PubMed ID: 12663847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity in schizophrenia: screening, monitoring, and health promotion.
    Beebe LH
    Perspect Psychiatr Care; 2008 Jan; 44(1):25-31. PubMed ID: 18177275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introduction. Weight gain with psychotropics: size does matter.
    Masand PS
    J Clin Psychiatry; 1999; 60 Suppl 21():3-4. PubMed ID: 10548134
    [No Abstract]   [Full Text] [Related]  

  • 25. Schizophrenia and weight management: a systematic review of interventions to control weight.
    Faulkner G; Soundy AA; Lloyd K
    Acta Psychiatr Scand; 2003 Nov; 108(5):324-32. PubMed ID: 14531752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
    Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
    J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An overview of the central control of weight regulation and the effect of antipsychotic medication.
    Tighe S; Dinan T
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):36-46. PubMed ID: 16280336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
    Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
    Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weight change with atypical antipsychotics in the treatment of schizophrenia.
    Haddad P
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):16-27. PubMed ID: 16280334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.
    Popp J; Leucht S; Heres S; Steimer W
    Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of antipsychotic-induced weight gain.
    McIntyre RS; Mancini DA; Basile VS
    J Clin Psychiatry; 2001; 62 Suppl 23():23-9. PubMed ID: 11603882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Description of a healthy lifestyle intervention for people with serious mental illness taking second-generation antipsychotics.
    Park T; Usher K; Foster K
    Int J Ment Health Nurs; 2011 Dec; 20(6):428-37. PubMed ID: 21564457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Schizophrenia, obesity and pharmacotherapy-associated weight gain].
    Carpiniello B; Corda E; Maccioni R; Pinna F
    Clin Ter; 2008; 159(5):299-306. PubMed ID: 18998030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addressing adverse effects of antipsychotic treatment in young patients with schizophrenia.
    Correll CU
    J Clin Psychiatry; 2011 Jan; 72(1):e01. PubMed ID: 21272508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
    Kao YC; Liu YP
    Compr Psychiatry; 2010; 51(6):557-65. PubMed ID: 20965300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity, serious mental illness and antipsychotic drugs.
    Holt RI; Peveler RC
    Diabetes Obes Metab; 2009 Jul; 11(7):665-79. PubMed ID: 19476478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: a 12-month follow up.
    Chen CK; Chen YC; Huang YS
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):17-22. PubMed ID: 19067997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medications.
    Faulkner G; Cohn TA
    Can J Psychiatry; 2006 Jul; 51(8):502-11. PubMed ID: 16933587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Qualitative inquiry into motivators for maintaining medication adherence among Taiwanese with schizophrenia.
    Chang YT; Tao SG; Lu CL
    Int J Ment Health Nurs; 2013 Jun; 22(3):272-8. PubMed ID: 22882876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.